177Lu-PSMA-617 is characterized by a high binding affinity and internalization, together with a prolonged tumor uptake and rapid kidney clearance making it suitable for endoradiotherapy (ERT) (Pastorino et al., 2020). The gene discussed is FOLH1; the disease is neoplasm.